Navigation Links
Researchers identify 4 new targets for breast cancer
Date:6/11/2009

HOUSTON - Four suspects often found at the scene of the crime in cancer are guilty of the initiation and progression of breast cancer in mice that are resistant to the disease, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the June edition of Cancer Cell.

"We have a smoking gun" that shows it's no coincidence the three protein receptors and the enzyme that makes them are abnormally expressed in many types of cancer, said Gordon Mills, M.D., Ph.D., professor and chair of M. D. Anderson's Department of Systems Biology and senior author of the paper.

"We've compiled lots of evidence that they are associated with cancer, what's been missing is proof that they could cause cancer," Mills said. "There are no questions left, they should be targeted."

The four are three lysophosphatidic acid (LPA) receptors (LPA1, LPA2, and LPA3) and the LPA-producing enzyme, autotaxin. "Lysophosphatidic acid", Mills said, "is the single most potent known cellular survival factor." LPA binds to a series of G protein-coupled receptors to spark normal cell proliferation, viability, production of growth factors and survival. The Cancer Cell paper shows this powerful network is hijacked to initiate breast cancer and fuel tumor growth, invasion and metastasis.

The team took a strain of mice that is highly resistant to breast cancer and then created four transgenic strains, each strain expressing one of the receptors or autotaxin.

At 24 months, none of the 44 original cancer-resistant mice developed mammary gland cancer. Only one case of inflammation and two cases of a potentially precancerous accumulation of cells known as hyperplasia were noted.

Cancer incidence ranged from 32 percent to 52.8 percent in the four strains of mice with one of the culprit receptors or autotaxin. Invasive and/or metastatic tumors were present to varying degrees, with 45.5 percent of the tumors i
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers identify 4 new targets for breast cancer
(Date:5/5/2015)... RF Technologies®, a leading provider of personal safety ... Solution with Voice Alarms. The ST750 will play a ... wait for assistance when it detects them starting to ... different melodies or tones or silent alerting, by integrating ... Alert®. , For 28 years, Sensatec Fall Management ...
(Date:5/5/2015)... Rafael, CA (PRWEB) May 05, 2015 ... in 2012, with the belief that ultimate Frisbee™ is ... be the next sport that engages the world. Nike ... youth level, by creating opportunities for young athletes to ... this collaboration with MLU the perfect fit. , The ...
(Date:5/5/2015)... 05, 2015 NovaSom, Inc., announced today ... of Innovations with Ed Begley Jr., airing via Discovery ... , This segment will focus on NovaSom, a leader ... learn about their AccuSom® home sleep test, which is ... continuous patient support and next-day test results and interpretation. ...
(Date:5/5/2015)... 2015 Every year, news articles appear warning ... the worst dry eye season is spring, also known as ... of the United States. The only season offering a respite ... Kleyne, host of the Sharon Kleyne Hour™ Power of Water® ... show of May 11, 2015. Kleyne is the inventor of ...
(Date:5/5/2015)... 05, 2015 McMunn Associates , ... automation solutions, announced today that it has officially launched ... identity. According to president and founder, Larry McMunn, the ... the company’s strategy for growth and expansion for the ... the past 30 years by building close, personal relationships ...
Breaking Medicine News(10 mins):Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 3Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3Health News:McMunn Associates Launches New Corporate Branding with New Website 2
... treatments, better patient outcomes , , WEDNESDAY, March 12 (HealthDay ... patients at risk of developing acute kidney injury (AKI) ... problem would otherwise be detected, a pilot study shows. ... better patient outcomes, the researchers say. , The test ...
... sights on renewed growth, IRWINDALE, Calif., March 12 ... including diet bars and,powdered mixes, today announced the appointment ... and consumer products sectors: Allan,Lutz, Scott Meader and Hugh ... of the company., Mr. Lutz has more than ...
... first "test-tube" baby was born in July 1978 - the ... couples in developed countries. There, we have seen more than ... in some countries, as many as 4 per cent of ... The plight of couples in developing countries, especially women, has ...
... market, WASHINGTON, March 12 Groundbreaking research,on ... impact on Medicare costs. The new study by,America,s ... in the,journal Health Affairs. AHIP also released a ... Medigap enrollment has remained constant in recent,years, showing ...
... ISTA,Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced ... Health Care Conference at 3:55 p.m. Eastern,Daylight Time on ... Hotel,in Boston, MA., ISTA,s President and Chief Executive ... the Company,s commercial and clinical,progress. To access the live ...
... announces Progress in Osteoporosis now available FREE online , ... mouse click away , The International Osteoporosis Foundation has ... is now available free online to help readers keep ... developments. , Progress in Osteporosis provides a timely update ...
Cached Medicine News:Health News:New Test Predicts Risk of Post-Surgery Kidney Injury 2Health News:Nellson Nutraceutical Names New Directors and Interim Chief Executive Officer 2Health News:Fertility in developing countries: words into action 2Health News:New AHIP Study in Health Affairs Challenges Previous Assumptions About Medigap's Impact on Medicare Costs 2Health News:New AHIP Study in Health Affairs Challenges Previous Assumptions About Medigap's Impact on Medicare Costs 3
(Date:5/5/2015)... Bio-Techne Corporation (NASDAQ: TECH ) announced ... a dividend of $0.32 per share for the quarter ... payable May 29, 2015 to all common shareholders of ... be considered by the Board of Directors on a ... ) is a global life sciences company providing innovative ...
(Date:5/5/2015)... 5, 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: ... that specializes in developing safer, more effective cannabis-based ... investor, and Non-Executive Director, Peter Mountford , ... with primary responsibility for the European markets. ... leverage his previous success in the emerging field ...
(Date:5/4/2015)... May 4, 2015  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, ... financial results for the first quarter ended March 31, ... "Following our equity offering in February, ... we are in a strong financial position to ...
Breaking Medicine Technology:InMed Engages Peter Mountford as Strategic Advisor 2InMed Engages Peter Mountford as Strategic Advisor 3InMed Engages Peter Mountford as Strategic Advisor 4Xencor Reports First Quarter 2015 Financial and Operating Results 2Xencor Reports First Quarter 2015 Financial and Operating Results 3Xencor Reports First Quarter 2015 Financial and Operating Results 4Xencor Reports First Quarter 2015 Financial and Operating Results 5Xencor Reports First Quarter 2015 Financial and Operating Results 6Xencor Reports First Quarter 2015 Financial and Operating Results 7Xencor Reports First Quarter 2015 Financial and Operating Results 8
... the journal Blood found 92 percent reduction in ... ... Patients with a rare,blood disorder called PNH experienced a 92 ... treatment,with Soliris(TM) (eculizumab), according to an analysis of clinical studies,recently ...
... Groundbreaking 2002 ... ... study reveals that,coiling, a minimally invasive procedure to treat aneurysms in ... treatment in those aneurysms considered "untouchable" by the,traditional surgical option. One ...
Cached Medicine Technology:PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 3
... RiOs systems produce Type III, laboratory-grade ... Systems are fed directly with potable tap ... a compact system design that is easy ... over the water produced at a low ...
... ArcticTemp Ultra Low Freezers -85C offer efficiency ... Features: Compressor life is extended by an ... a constant flow of refigerant. Heat is ... condenser with three fans. Monitoring light to ...
... U570 is an upright freezer, built ... models. Comparable in size to Innova ... cascade refrigeration and urethane insulation, for ... 400 2" boxes. Includes five compartments ...
... freezer, with over 23 cu. ft. storage ... Built to the same standards as Innova ... cost-saving alternative. Rust-resistant, powder coated exterior; top-quality ... adjustable shelves. Keyed lock and 4-digit password ...
Medicine Products: